Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMen: Protein and Testosterone for Mobility Limitation in Older Men
NCT01275365Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of testosterone enanthate, sponsored by Brigham and Women's Hospital. Started May 2011; status: completed.
02
Drugs
testosterone enanthate
Beyond the preview
Go deeper on NCT01275365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01275365.